Costs were evaluated using descriptive methods.
Additionally electricity generation costs were evaluated.
The effects on redress life and costs were evaluated.
Health care costs were evaluated based on third party payer perspective.
Costs were evaluated in relation to health-related quality of life.
The results and costs were evaluated in terms of Pb removal, which was taken as the representative toxic metal.
Overall, the total costs, including direct and indirect costs, were evaluated to be 33.67 € for frovatriptan and 59.38 € for rizatriptan, respectively.
This systematic review assessed how oncological home-hospitalization has been organized and to what extent its quality and costs were evaluated.
The implications of life cycle environmental impacts and life cycle costs were evaluated and the optimum assemblage design is reported using optimization algorithm.
Overall, total costs, including direct and indirect costs, were evaluated to be 33.67 € for frovatriptan and 59.38 € for rizatriptan, respectively, as shown in Figure 3. Figure 3 Direct (full bars) and indirect (open bars) costs per migraine attack.
Objective: Glycemic control, perinatal outcome, and health care costs were evaluated among women with type 1 diabetes mellitus who began insulin pump therapy during pregnancy (group 1, n = 24), were treated with multiple insulin injections (group 2, n = 24), or were already using an insulin pump before pregnancy (group 3, n = 12).
